Methods of treatment comprising administering a high daily dose of oxycodone and naloxone in a 2:1 weight ratio
WO2018068832A1
Hodgkin lymphoma therapy
AU2016301861A1
A prolonged release dosage form comprising oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof in the treatment of bladder pain syndrome (BPS)
WO2016116615A1
A combination of hydromorphone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
WO2016110527A1
Process for manufacture of forodesine
GB201520390D0
Composition
GB201520391D0
Compound
AU2015258185A1
Counter
GB201513442D0
Transdermal patch
GB201513441D0
Transdermal delivery system
GB201513443D0
Patch
GB201409471D0
Pharmaceutical composition
GB201409485D0
Pharmaceutical composition
GB201409488D0
Pharmaceutical composition
US2014066475A1
Method For Treating Pruritus
GB201309654D0
Method
AU2013204227A1
Method of providing sustained analgesia with buprenorphine
AU2013204813A1
Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
